InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Haskel William M., Executive. Officer active across 1 company, notably Paratek Pharmaceuticals, Inc.. Aggregated, 15 disclosures have been published. Split: 0 buy · 4 sells. Total volume traded: €80k. History available since 27 May 2021. The latest transaction was filed on 8 August 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations15 total
357,774 sharesCommon StockSEC:0000899243-23-019361:0
73,750 shares0Common StockSEC:0000904454-23-000474:0
15,000 shares0Common StockSEC:0000904454-22-000651:0
14,410 shares@ US$1.9833.7% of flowCommon StockSEC:0000904454-22-000625:0
4,382 shares@ US$3.4719.0% of flowCommon StockSEC:0000904454-22-000530:0
9,250 shares0Common StockSEC:0000904454-22-000508:0
47,727 shares0Common StockSEC:0000904454-22-000427:0
67,500 shares0Common StockSEC:0000904454-22-000266:0
4,876 shares@ US$4.4223.7% of flowCommon StockSEC:0000904454-21-000842
4,876 shares@ US$4.4250.0% of flowCommon StockSEC:0000904454-21-000842:0
23,125 shares0Common StockSEC:0000904454-21-000628:0
23,125 shares0Common StockSEC:0000904454-21-000628
28,636 shares0Common StockSEC:0000904454-21-000518:0
28,636 shares0Common StockSEC:0000904454-21-000518
11,000 sharesCommon StockSEC:0000904454-16-000928:0
15 of 15 declarations
About Haskel William M.
William M. Haskel is the CLO, General Counsel, and Secretary of Paratek Pharmaceuticals, Inc. In this role, he is responsible for the company's legal affairs and regulatory compliance. His expertise in business law is essential for Paratek's strategy.
